Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
06 99 39
Recup number
You may also be interested in:
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.
Authors: Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodríguez-Mañas L, Fried LP, Woo J, Aprahamian I, Sanford A, Lundy J, Landi F, Beilby J, Martin FC, Bauer JM, Ferrucci L, Merchant RA, Dong B, Arai H, Hoogendijk EO, Won CW, Abbatecola AM, Cederholm T, Strandberg T, Gutiérrez Robledo LM, Flicker L, Bhasin S, Aubertin-Leheudre M, Bischoff-Ferrari HA, Guralnik JM, Muscedere J, Pahor M, Ruiz J, Negm AM, Reginster JY, Waters DL, Vellas B
Date: 2019
Scope of interest: geriatrics
Read details
Rosiglitazone And Cognitive Stability In Older Persons With Type 2 Diabetes And Mild Cognitive Impairment
Authors: Abbatecola AM, Lattanzio F, Molinari AM, Ciuffi M, Mansi L, Rambaldi P, DiCioccio L, Cacciapuoti F, Canonico R, Paolisso G.
Date: 2010
Scope of interest: diabetes
Read details
The efficacy of Choep chemotherapy regimen administered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneous involvement (PTCL)
Authors: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.
Date: 2013
Scope of interest: Haematology
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
